Articles
Haiwen Chen, M.D., Ph.D. and David Hale, M.D. Join Department of Neurology
Haiwen Chen is a pediatric neurologist who specializes in caring for children with pediatric onset neuroinflammatory and neuroinfectious diseases and David Hale is a fellowship-trained neurologist who specializes in neurovisual and vestibular disorders.
Beyond identifying specific functions of individual brain regions, there has been significant interest in understanding how multiple regions interact to perform various functions. However, there are many theories but few conclusions regarding ...
New Johns Hopkins Study Examines Prevalence of Epilepsy in Sexual and Gender Minorities in the U.S.
Recent research highlights that transgender and gender diverse (TGD) people in the United States report reduced health-related quality of life compared to people who are cisgender.
New Multidisciplinary Clinic for Patients with Neurological Cancers
Johns Hopkins offers advanced approach to brain cancers in the Greater Washington Area.
Pediatric Neurosurgery Research on Hydrocephalus and Chiari Malformation at Johns Hopkins
Ongoing studies focused on these conditions will innovate care at Johns Hopkins and beyond.
Paving a Path for Treating Pediatric Moyamoya
Johns Hopkins neurologist Lisa Sun tackles knowledge gaps in research on the rare blood vessel disorder.
Neurologists Test App Developed at Johns Hopkins to Diagnose Stroke
Researchers study whether smartphone app can identify stroke using an approach and technological principles pioneered at the institution.
Researchers at Johns Hopkins Medicine, in collaboration with researchers at the National Institutes of Health, report that two new studies in mice with a humanized immune system and human cell lines have identified an enzyme that plays ...
Performing a Minimally Invasive Approach for Spinal Tumor Resection
Johns Hopkins neurosurgeons eschew open surgery to help a patient with metastatic breast cancer quickly return to her active lifestyle.
Abdullah AlQahtani, M.D., M.P.H.
Abdullah AlQahtani specializes in inherited and noninherited neuromuscular neurological diseases.
Johns Hopkins Research Suggests New Promise for Patients with ALS
Neurologist Nathan Crone and colleagues demonstrate the potential of implanted brain-computer interfaces to overcome speech and movement impairments for people with the condition.
Brain-Computer Interface Restores Control of Home Devices for Johns Hopkins Patient with ALS
A BCI decodes neural signals acquired from electrodes placed on the surface of brain areas responsible for speech and upper limb function. Participant then navigates options on a communication board using a set of six navigational commands ...
Treating Patients With Complex Brain Tumors
Neurosurgeon Youssef Comair specializes in craniotomies to remove falcotentorial meningiomas.
New Research and Insights into Neuromodulation
Johns Hopkins team unravels novel ways to improve the therapy.
The Invisible Impact of Minor Stroke
Johns Hopkins neurologist Elisabeth Breese Marsh shares potential new roads to recovery after small infarcts.
Neurosurgeons at Johns Hopkins Bayview Medical Center Incorporate New, Innovative Imaging Devices
Employing a robotic exoscope and a mobile CT X-ray system, clinicians aim for better outcomes for patients.
Investigators Devise Test to Identify Brain Tumors from Cerebrospinal Fluid
Researchers with the Johns Hopkins Kimmel Cancer Center, the Johns Hopkins University School of Medicine and four other institutions have developed a molecular test to identify the presence of brain tumors by measuring abnormal genetic ...
Investigators Devise Novel Test to Identify Brain Tumors from Cerebrospinal Fluid
Researchers with the Johns Hopkins Kimmel Cancer Center, the Johns Hopkins School of Medicine and four other institutions have developed a molecular test to identify the presence of brain tumors.
How an innovative funding approach is advancing research and speeding treatments for patients whose complicated disorder can cause tumors on nerves all over the body. Every grant made by the Neurofibromatosis Therapeutic Acceleration Program, ...
Johns Hopkins neurosurgeons are among the first in the U.S. to use magnetic resonance guided focused ultrasound, also known as MRgFUS, to investigate how it may be applied to ablate diseased tissue and traverse the blood-brain barrier.
Better Understanding of Chiari Malformation
Johns Hopkins’ participation in the Chiari Surgical Success Scale and a similar study for nonsurgical patients could help doctors make better treatment decisions.
This gel stops brain tumors in mice. Could it offer hope for humans?
The gel can reach areas that surgery might miss and current drugs struggle to reach to kill lingering cancer cells and suppress tumor growth.
Minimally Invasive Spine Surgeries Offer Better Outcomes, Faster Recovery
Neurosurgeon David Lin discusses the benefits of artificial cervical disk replacement and microdiscectomy.
Identifying the Seizure Onset Zone Through Single-Pulse Electrical Stimulation
New study by Johns Hopkins researchers could significantly shorten monitoring time before epilepsy surgery and improve outcomes
Forty Years of Neurocritical Care
One of the world’s first neurosciences critical care units opened at Johns Hopkins in 1982, innovating patient care and inspiring hundreds of similar efforts globally.
Taking a Deeper Look at Trigeminal Neuralgia
Risheng Xu’s research aims to unravel the nature of the puzzling condition — from bench to bedside.
Johns Hopkins Researchers Make New Discoveries in Neurology and Neurosurgery
Physicians and scientists within the institution bolster understanding in both fields, with the aim of enhancing patient care.
New Tools Map Seizures, Improve Epilepsy Treatment
Two new models could solve a problem that’s long frustrated millions of people with epilepsy and the doctors who treat them: how to find precisely where seizures originate to treat exactly that part of the brain.
DREZ Lesioning for Pain from Nerve Avulsion
John Hopkins neurosurgeon provides dorsal root entry zone lesioning - available at few other medical centers in the nation - to treat subset of chronic pain.
Harnessing the Healing Power of Music
The Zoom meetup begins with Jason Armstrong Baker playing a melody on a metal drum to welcome his class. Five people log in to the weekly, one-hour session, hosted by the Johns Hopkins Center for Music and Medicine, during which Baker ...
Johns Hopkins Researchers Identify a Potential Window for Treating ALS
Johns Hopkins Medicine researchers have found a possible window of opportunity during ALS treatment to target astrocyte abnormalities — a subtype of cells in the central nervous system that provide a structure to metabolically support ...
Researchers Aim to Improve Lifespan and Quality of Life for Patients with Brain Tumors
Johns Hopkins neurosurgeon-scientists test a gamut of new therapeutic approaches — such as using bioengineered cancer cells to produce neoantigens that activate immune response. They simultaneously develop new tools and techniques to improve quality of life.
Leading-Edge Approaches and Research to Improve Surgical Spine Treatments and Outcomes
Spine neurosurgeons use technologies co-developed by faculty members to advance patient care. Plus, a first-of-its-kind lab creates a new class of implantable, wearable medical devices to aid those with spinal cord injuries.
Four Years After Inception, Sheikh Khalifa Stroke Institute Is Changing Lives
Clinician-scientists develop technologies and conduct research to improve outcomes for patients with stroke globally, including integration of imaging, and clinical and genetic data to develop a precision medicine program.
Johns Hopkins Pediatric Epilepsy Surgery Program Expands
Pediatric epileptologist Ahmad Marashly joins as multidisciplinary experts use new technologies and resources to provide potentially curative options for young patients. The program is among the few of its kind in the U.S.
A New Application of Deep Brain Stimulation for Treatment-Resistant Schizophrenia
Johns Hopkins researchers report that after 24 weeks of deep brain stimulation to a particular part of the organ, a patient’s long-experienced hallucinations and suspicious delusions entirely ceased.
Johns Hopkins Medicine Puts Fat to Good Use as Stem Cell Source for Spinal Fusion Surgery
Researchers at Johns Hopkins Medicine suggest there’s another role for the poor maligned adipose cell: a practical and plentiful source of stem cells for use in spinal fusion surgeries.
Researchers Identify Inflamed Brain Cells Likely Involved in MS Nerve Degeneration
MRI scans of a patient’s brain showing the chronic active lesions (areas of localized damage marked by arrows within magnified insets) associated with multiple sclerosis (MS). Johns Hopkins Medicine and National Institute of Neurological ...
$14 Million Grant to Fund Clinical Trial to Study Effectiveness of Hydrocephalus Treatment
Patients diagnosed with idiopathic normal pressure hydrocephalus (iNPH), a type of brain swelling most commonly seen in older adults — and for which the underlying cause is unknown — are typically treated by surgically installing a shunt ...
Caring for Epilepsy Patients Across Life’s Continuum
By following certain patients for long periods — sometimes from childhood through adulthood — the Johns Hopkins epilepsy team helps protect patients from problems that can occur during various stages of their lives.
Johns Hopkins Medicine Helps Create Treatment Guide for Neurodegenerative Disorders
Some people may think nothing can be done for neurodegenerative disorders such as progressive supranuclear palsy (PSP) and corticobasal syndrome (CBS). However, a Johns Hopkins Medicine researcher and his colleagues are adamant that is not the case.
A Potential New Target to Fight Glioblastoma
Study by Johns Hopkins and Tel Aviv University scientists suggests that immune molecule P-selectin could play a key role in deadly brain tumors.
Advanced DNA Sequencing for Problems of the Central Nervous System
Developed at Johns Hopkins, a next-generation technique helps neurologists identify hard-to-diagnose brain infections. Johns Hopkins is one of the few academic medical centers offering the approach in the U.S.
Targeting Abnormal Cell Metabolism Shows Promise for Treating Aggressive Pediatric Brain Tumors
Two experimental drug approaches that target vulnerabilities in cancer cell metabolism may extend survival and enhance the effectiveness of standard chemotherapies for a highly aggressive type of pediatric brain cancer.
Digging Deeper to Understand How Humans Learn Motor Skills After Brain Injury
Johns Hopkins researchers continue study into brain stimulation — reinforced with repetitive learning strategies — to increase motor function after stroke. Findings could enable clinicians to develop approaches to reinforce learning, in ...
Comprehensive Care for Patients with Cerebrospinal Fluid Conditions
Johns Hopkins’ Cerebral Fluid Center is among the few in the United States that can diagnose and treat the full spectrum of such disorders.
Johns Hopkins Medicine Helps Find Cause of Guillain-Barre Syndrome Outbreak in Peru
In the spring of 2019, Peruvian neurologists saw a significant increase in the number of patients with Guillain-Barre syndrome (GBS). This rare disorder occurs when a person’s immune system damages the nerves, causing muscle weakness and sometimes paralysis.
Johns Hopkins Performs Its First Augmented Reality Surgeries in Patients
Johns Hopkins neurosurgeons have performed the institution’s first augmented reality surgeries in living patients.
Minor Strokes Lead to Global Disruptions in Brain Signaling and Cognitive Dysfunction
Johns Hopkins Medicine researchers and colleagues at the University of Maryland have found what is believed to be the first measurable physical evidence of diminished brain processing after a minor stroke.
Individualized Care Through Translocation Testing
Johns Hopkins is among the few centers in the U.S. that identify tumors’ unique features using on-site fusion tests.
Innovations in Care for Patients with Pediatric Epilepsy
For difficult epilepsy cases, Johns Hopkins experts use the latest, less invasive diagnostic and treatment tools.
Gene Therapy for Duchenne Muscular Dystrophy
A new clinical trial set to begin in early 2021 at Johns Hopkins will test an innovative way of treating the devastating genetic disorder.
Developing Implantable and Wearable Technology to Treat Spinal Cord Injury
Johns Hopkins neurosurgeons and biomedical engineers work to create wearable and implantable devices enabling continuous, postoperative treatment of acute, subacute and chronic spinal cord injury. The effort is funded by a $13.48 million ...
New study by Johns Hopkins Medicine neuroplastic and reconstructive surgeons under Chad Gordon shows “undercover” implant between scalp and skull successfully treats brain swelling known as hydrocephalus.
Neurological Conditions and COVID-19
In this Q&A, Robert Stevens, associate director of the Neurocritical Care Precision Medicine Center of Excellence, shares insights on assessing patients presenting with COVID-19 and neurological symptoms.
New Research: Electrospinning to Deliver Multiple Chemotherapy Drugs to the Brain
A recently published Johns Hopkins study — conducted in collaboration with the University of Cincinnati — shows how electrospun fibers could simultaneously dispense more than one chemotherapy agent to brain tumors.
A New Era of Clinical Research for ALS
A number of Johns Hopkins-led clinical trials focus on disease targets that represent completely new avenues for fighting amyotrophic lateral sclerosis.
New Field Developed at Johns Hopkins to Preserve Appearance After Neurosurgery
Neuroplastic surgery represents a historic shift in approach, addressing the often stigmatizing physical side effects of neurosurgery.
A Potential Breakthrough for Patients with Drug-Resistant Epilepsy
New medication tested in clinical trials at Johns Hopkins and elsewhere shows dramatic results for patients with focal onset seizures.
A new epilepsy monitoring unit at Johns Hopkins incorporates decades of experience and technological advances of an all-ages unit into one designed for pediatric patients only.
Surgery May Add Months or Years of Survival For Adults With Rare And Deadly Brain Cancers
Findings from medical records study could help doctors and patients make more informed treatment decisions
Improving the Efficiency of Clinical Trials
Johns Hopkins neurologist Dan Hanley co-leads Trial Innovation Center, helping researchers solve roadblocks to efficacy and lower costs.
A Rare Diagnosis of Spinal Cord Stroke and the Road to Recovery
Under the care of experts at the Johns Hopkins Transverse Myelitis Center, a patient overcomes odds to walk again after rare and devastating neurological event.
For Spinal Fusion: Certain Antihypertensive Drugs May Improve Outcomes
New Johns Hopkins research suggests that blood pressure-lowering medicines can speed or inhibit bone healing.
A Clinical Innovation: Shortening the Spinal Column to Loosen Tethered Cords
Johns Hopkins neurosurgeons provide spina bifida patients new option to avoid ongoing detethering operations.
Investigational Drug for People with Treatment-Resistant Epilepsy
Hope may be on the horizon for epilepsy patients who have had limited success with seizure drugs.
Potential Genetic Markers of Multiple Sclerosis Severity
Identifying ways to predict who will develop more severe multiple sclerosis.
Electrical Stimulation Aids in Spinal Fusion
Electrical stimulation devices in spinal fusions recommended for most at-risk patients.
Researchers Repair Faulty Brain Circuits Using Nanotechnology
Possible new drug targets for dementia and intellectual disability
Research Points to Genetic Underpinnings of Olfactory Neuroblastoma
The study, led by Johns Hopkins neurosurgeon-scientists, sheds light on the mechanisms involved in cancer and could lead to new treatments for olfactory neuroblastoma. Image shows cellular image of neuroblastoma.
Improving Neurosurgical Outcomes Through Mental Health
By involving a rehabilitation psychologist and an expert on decreasing opioid use in patient care, the spine team aims to bolster the patient experience before and after surgery.
Precision Medicine for Patients with Neurofibromatosis
Neurofibromatosis Precision Medicine Center of Excellence works to mine untapped volumes of clinical data and use it for research that can benefit patients with neurofibromatosis.
Mid- to Late-Life Increases in Marker of Chronic Inflammation Tied to Dementia
News & Publications
Johns Hopkins and the United Arab Emirates Launch Sheikh Khalifa Stroke Institute
News Release February 2017
Treating a Spectrum of Neurosurgical Conditions: From Infancy to Adulthood
Pediatric NeuroNews December 16, 2016
Adult Neurology: 410-955-9441
Pediatric Neurology: 410-955-4259
Adult Neurosurgery: 410-955-6406
Pediatric Neurosurgery: 410-955-7337